Pricing Log in Create free account

Lexaria Bioscience Corp. (LEXX) vs VistaGen Therapeutics, Inc. (VTGN)

Lexaria Bioscience Corp. and VistaGen Therapeutics, Inc. are both Biotechnology companies. Lexaria Bioscience Corp. is the larger, with a market value of $8.8M against $7.3M — 1.2× the size. VistaGen Therapeutics, Inc. grew revenue faster over the last twelve months: 287.2% against 9.08%. Lexaria Bioscience Corp. has the higher net margin (0.00% vs −2,703.7%) and the lower return on invested capital (−662.6% vs 0.00%). Across the 16 metrics below, Lexaria Bioscience Corp. leads on 9 and VistaGen Therapeutics, Inc. on 7.

Valuation

Metric LEXX VTGN Biotechnology median
P/E n/m n/m 10.26
P/S 12.64 2.92 9.18
P/B 1.58 0.30 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 0.23 0.65
EV/Sales 6.08 (6.44) 8.98
Earnings yield (126.07%) (976.47%) (34.89%)
Free cash flow yield (109.89%) (854.68%) (24.52%)

Profitability

Metric LEXX VTGN Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin 0.00% (2,785.69%) 0.00%
Net margin 0.00% (2,703.72%) 0.00%
Free cash flow margin 0.00% (2,490.88%) 0.00%
Return on equity (162.60%) (166.46%) (50.12%)
Return on assets (134.20%) (129.22%) (45.60%)
Return on invested capital (662.56%) 0.00% 0.00%

Growth

Metric LEXX VTGN Biotechnology median
Revenue growth (TTM) 9.08% 287.15% 6.26%
EPS growth (last fiscal year) (40.43%) (9.58%) 29.88%
Revenue growth, 5-year CAGR 17.53% 3.10% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LEXX VTGN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 10.60 3.07 4.89
Net debt to EBITDA 0.17 0.63 1.01

Dividend

Metric LEXX VTGN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric LEXX VTGN Biotechnology median
Market cap 8.78m 7.33m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack